CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
CRISPR Therapeutics has raised €116M across 3 funding rounds from 12 investors, most recently a Series B round in Jun 2016. Based in Basel, Switzerland; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€116M
€116,485,082
Funding rounds
3
Investors
12
distinct backers
Active since
2014-04
latest 2016-06
Funding by year
EUR raised per yearCRISPR Therapeutics — funding by year — interactive chart.
Data table
| CRISPR Therapeutics — funding by year | |
|---|---|
| 2014 | €23M |
| 2015 | €59M |
| 2016 | €35M |
Signals
High confidenceRaise-next likelihood8
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-06-01 | Series B | €35M | Clough Capital Partners,Franklin Templeton Investments,New Leaf Venture Partners,Wellington Partners | View deal → |
| 2015-04-01 | Series B | €59M | Abingworth LLP,Bayer Global Investments,Celgene,GlaxoSmithKline,New Enterprise Associates,SR One+2 more | View deal → |
| 2014-04-01 | Series A | €23M | Versant Ventures | View deal → |
Investors
12Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData